Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer

Small-cell lung cancer (SCLC) is a highly malignant type of lung cancer with no effective second-line chemotherapy drugs. Arsenic trioxide (As(2)O(3)) was reported to exert antiangiogenesis activities against lung cancer and induce poor development of vessel structures, similar to the effect observe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Meng-Hang, Chang, Ke-Jie, Li, Bing, Chen, Wan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481139/
https://www.ncbi.nlm.nih.gov/pubmed/31093499
http://dx.doi.org/10.1155/2019/4647252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481139/
https://www.ncbi.nlm.nih.gov/pubmed/31093499
http://dx.doi.org/10.1155/2019/4647252

Ejemplares similares